{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:52:58Z","timestamp":1784231578589,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Isoelectric focusing (IEF) of serum transferrin (Tf) is still the method of choice for diagnosis of congenital disorders of glycosylation (CDG). An abnormal glycosylation is also a known phenomenon in adult liver disease patients. The aim of this study was to characterize glycosylation disturbances in pediatric patients with primary liver disease. However, there are no reports of this phenomenon in children.<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> Between 1995 and 2019, circa 2,000 serum Tf isoform analyses have been performed in children with primary liver diseases; some of them underwent subsequent analyses. We enrolled in this study 19 patients who developed an acute liver injury (ALI)\/failure (ALF) or exhibited a chronic liver disease (CLD) and were evaluated and listed for liver transplantation (LTx) or had just undergone this procedure, and secondary abnormal serum Tf isoform profile.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Among 12 patients with ALI\/ALF, 10 had an increased percentage of asialo-, monosialo-, and disialo-Tf isoforms. All patients with CLD had an increased percentage of asialo- and monosialo-Tf isoform. Two patients diagnosed with recurrent ALF had very specific serum Tf profile with a huge increase in the asialo- and monosialo-Tf isoform. On follow-up analyses (available in some patients), serum Tf IEF profile normalized in parallel to normalization of liver function tests, spontaneously or during treatment, including glucocorticosteroids in AIH, LTx in CLD.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> All pediatric patients with primary liver disease had increased asialo-Tf as well as monosialo-Tf isoforms. None of them had elevated percentage of trisialo-Tf isoform.<\/jats:p>","DOI":"10.3389\/fped.2020.613224","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T07:58:03Z","timestamp":1610611083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Pediatric Liver Disease Patients and Secondary Glycosylation Abnormalities"],"prefix":"10.3389","volume":"8","author":[{"given":"Anna","family":"Bogda\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Lipi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Szyma\u0144ska-Ro\u017cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Socha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tylki-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10545-016-0012-4","article-title":"Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature","volume":"40","author":"Marques-da-Silva","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2018.11.003","article-title":"The challenge of CDG diagnosis","volume":"126","author":"Francisco","year":"2019","journal-title":"Mol Genet Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ejmg.2017.10.012","article-title":"Congenital disorders of glycosylation (CDG): Quo vadis?","volume":"61","author":"P\u00e9anne","year":"2018","journal-title":"Eur J Med Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0009-8981(90)90278-Z","article-title":"The biology of transferrin","volume":"190","author":"de Jong","year":"1990","journal-title":"Clin Chim Acta"},{"key":"B5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0009-8981(82)90060-2","article-title":"The heterogeneity of human serum transferrin and human transferrin preparations on isoelectric focusing gels: no functional difference of the fraction in vitro","volume":"121","author":"Van Eijk","year":"1982","journal-title":"Clin Chim Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jhep.2008.12.010","article-title":"Alteration of protein glycosylation in liver diseases","volume":"50","author":"Blomme","year":"2009","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33927","DOI":"10.1038\/srep33927","article-title":"Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease","volume":"6","author":"H\u00fclsmeier","year":"2016","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/clinchem\/37.12.2029","article-title":"Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed","volume":"37","author":"Stibler","year":"1991","journal-title":"Clin Chem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/glycob\/cwg016","article-title":"The effects of ethanol on the glycosylation of human transferrin","volume":"13","author":"Flahaut","year":"2003","journal-title":"Glycobiology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4065\/78.6.703","article-title":"Value of determining carbohydrate-deficient transferrin isoforms in the diagnosis of alcoholic liver disease","volume":"78","author":"Stadheim","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/liv.13362","article-title":"Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease","volume":"37","author":"Clarke","year":"2017","journal-title":"Liver Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"29797","DOI":"10.1074\/jbc.M605697200","article-title":"Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts","volume":"281","author":"Nakagawa","year":"2006","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/bmc.167","article-title":"A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases","volume":"16","author":"Anderson","year":"2002","journal-title":"Biomed Chromatogr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1111\/j.1572-0241.2007.01405.x","article-title":"Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis","volume":"102","author":"Sterling","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"E2894","DOI":"10.3390\/jcm9092894","article-title":"Changed profile of serum transferrin isoforms in primary biliary cholangitis","volume":"9","author":"Grytczuk","year":"2020","journal-title":"J Clin Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.7754\/Clin.Lab.2016.160636","article-title":"Changed profile of serum transferrin isoforms in liver diseases","volume":"63","author":"Gudowska","year":"2017","journal-title":"Clin Lab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/alcalc\/agw069","article-title":"Relationship of abnormal chromatographic pattern for carbohydrate-deficient transferrin with severe liver disease","volume":"52","author":"Stewart","year":"2017","journal-title":"Alcohol Alcohol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.clinbiochem.2017.06.013","article-title":"The transferrin isoforms in chronic hepatitis","volume":"50","author":"Gruszewska","year":"2017","journal-title":"Clin Biochem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cca.2008.03.033","article-title":"Atypical serum transferrin isoform distribution in liver cirrhosis studied by HPLC, capillary electrophoresis and transferrin genotyping","volume":"394","author":"Arndt","year":"2008","journal-title":"Clin Chim Acta"},{"key":"B20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jchromb.2006.05.005","article-title":"Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001\u20132005","volume":"841","author":"Bortolotti","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10719-019-09906-x","article-title":"The diagnostic value of serum DSA-TRF in hepatocellular carcinoma","volume":"37","author":"Guan","year":"2020","journal-title":"Glycoconj J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jpeds.2005.12.051","article-title":"Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group","volume":"148","author":"Squires","year":"2006","journal-title":"J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MPG.0000000000001334","article-title":"Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"64","author":"Fawaz","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10545-015-9896-7","article-title":"Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts","volume":"39","author":"Staufner","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ajhg.2019.05.011","article-title":"RINT1 Bi-allelic variations cause infantile-onset recurrent acute liver failure and skeletal abnormalities","volume":"105","author":"Cousin","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"B28","unstructured":"A simple sequentially rejective multiple test procedure6570\n            HolmS\n          Scand J Stat61979"},{"key":"B29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc. Series B Stat Methodol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/jimd.12273","article-title":"Screening for abnormal glycosylation in a cohort of adult liver disease patients","volume":"43","author":"Jansen","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/17474124.2016.1179575","article-title":"Targeting endoplasmic reticulum stress in liver disease","volume":"10","author":"Wu","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0039-1681032","article-title":"Endoplasmic reticulum stress in metabolic liver diseases and hepatic fibrosis","volume":"39","author":"Maiers","year":"2019","journal-title":"Semin Liver Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J Hepatol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.613224\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T09:18:55Z","timestamp":1611134335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.613224\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":33,"alternative-id":["10.3389\/fped.2020.613224"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.613224","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"article-number":"613224"}}